Screener
Abbott ABT Nutritional Products — Total Assets
Other segment segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Abbott in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The source filing: Abbott’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:02 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-050134
| (in millions) | Total Assets / As of June 30, 2026 | Total Assets / As of December 31, 2025 |
|---|---|---|
| Established Pharmaceuticals | $3,819 | $3,540 |
| Nutritional Products | 5,278 | 4,791 |
| Diagnostic Products | 9,709 | 8,273 |
| Medical Devices | 11,406 | 10,689 |
| Total Reportable Segment Assets | $30,212 | $27,293 |
| Cash and investments | 6,714 | 9,857 |
| Goodwill and intangible assets | 52,455 | 29,561 |
| All other (c) | 19,834 | 20,002 |
Item 1. Financial Statements and Supplementary Data
FAQ
- What is Abbott's nutritional products — total assets?
- Abbott (ABT) reported nutritional products — total assets of $5.28B in Q2 2026.
- How has Abbott's nutritional products — total assets changed year-over-year?
- Abbott's nutritional products — total assets increased by 7.5% year-over-year, from $4.91B to $5.28B.
- What does nutritional products — total assets mean?
- The sum of all assets, including inventory, property, plant, equipment, and allocated intangible assets, specifically attributed to the nutritional products segment. This metric represents the capital base deployed to generate the segment's revenue.
Ask your AI about Abbott's nutritional products — total assets.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude